Correlations between Urologic and Head and Neck Cancers

Slides:



Advertisements
Similar presentations
Yasir Rudha, MD; Amr Aref, MD; Paul Chuba, MD; Kevin O’Brien, MD
Advertisements

Urothelial CA: Cancers of the Bladder, Ureter, and Renal Pelvis
PROSTATE CANCER Dr Samad Zare Assistant Proffesor of Urology Shaheed Sadoughi University of Medical Sciences.
Bladder Cancer, 2006 Overview and Current Treatment Don Lamm, MD Bladder Cancer, Genitourinary Oncology, Phoenix Clinical Professor, University of Arizona,
Urostomy Why? Patricia Anderson BSN RN CWOCN. The American Cancer Society’s estimates for bladder cancer in the United States for 2013 are: About 72,570.
Haematuria and Urinary Tract Tumours
Matthew Kilmurry, M.D. St. Mary’s General Hospital Grand River Hospital.
Dr. Abdelaty Shawky Dr. Gehan Mohamed
Treatment Localized disease: Radical nephrectomy. Metstatic disease: Radiation therapy. Immunotherapy PROGNOSIS: stage % 5yrs survival stageII 60%
Dr H.Niroomand M.D. Aja University Of Medical Sience Epidemiology & Etiology.
Eleni Galani Medical Oncologist
A randomized trial of prophylactic cranial irradiation (PCI) versus no PCI in extensive disease small cell lung cancer after a.
Adult Medical-Surgical Nursing
In the name of God Isfahan medical school Shahnaz Aram MD.
Surrogate End point for Prostate Cancer- Specific Mortality After RP or EBRT A D’Amico J Nat Ca Inst 95,
Prostate Cancer: A Case for Active Surveillance Philip Kantoff MD Dana-Farber Cancer Institute Professor of Medicine Harvard Medical School.
Current Role of Partial Cystectomy: Are we scarifying patient ’ s survival Dr Eric Li Department of Surgery Pamela Youde Nethersole hospital.
1 CANCER OF THE BLADDER. 2  Cancer of the bladder is the second most common urologic malignancy.  90% of all bladder cancers are transitional cell carcinomas,
Dr. Abdellatif Zayed Bladder Cancer.
Cancer Cx. Que-1 The most common gynecological malignancy in the world is – a) Vaginal Ca b) Cervical Ca c) Uterine Ca d) Ovarian Ca.
Improved Detection of Bladder Cancer in Diagnosis and Surveillance Patients Using a Point-of-Care Proteomic Assay Barry Stein, M.D. G. Katz, M.D. NMP22.
Prostate Cancer Screening in African American Men Mark H. Kawachi, MD FACS Director, Prostate Cancer Center City of Hope, National Medical Ctr.
Unexpected additional lung cancer in a patient with already known inflammatory myofibroblastic tumor detected on PET/CT Kaohsiung Veterans General Hospital.
SEER Provided Data Mohammad Afnan Baqai 12/3/2009.
Neoplasms of the bladder
UofT GU Oncology, 2004 CLINICAL CASES. UofT GU Oncology, y.o. female  Familiar history: Thyroid cancer (mother) Prostate cancer (father)  PMH:
Suspected Malignancy B 陳建佑. Symptoms Red Urinary Hesitance Urination.
Visceral Adiposity at Diagnosis Correlates with Tumor Size and Metastatic Progression in Clear Cell Renal Carcinoma A Shuster, MD (1), M Patlas, MD (1),
By Dr. Abdelaty Shawky Assistant professor of pathology
University Hospitals Portage Medical Center. Portage County has one of the highest annual incidence rates of bladder cancer in the state of Ohio. According.
Laryngeal Tumours presented by : Dr. Mona Ahmed A/Raheem ENT Surgeon Khartoum National Center for Ear, Nose and Throat Diseases and Head and Neck Surgery.
Breast cancer affects 1 in 8 women during their lives. 1 Population Statistics.
SEER Data Cancer Project Brett Langsjoen. SEER Surveillance, Epidemiology, and End Results Program of the National Cancer Institute (NCI) Purpose: Collect.
National Cancer Intelligence Network Outcome and the effect of age in 1318 patients with synovial sarcoma: Report from the National Cancer Intelligence.
LCC COL-1 See Pathologic Stage, Adjuvant Therapy, and Surveillance (LCC COL-3) Φ Φ Φ π π π Colon Cancer.
Head & Neck Ca. (Epithelial tumors) Mohamad KADRI. MD. Clinical oncology. Medical director of AlBerouni University Hospital President of Syrian Association.
Trends in bladder cancer treatments
Bladder Cancer Mark Browning, M.D. ‘ IUSME.
Premature deaths due to Prostate Cancer: The Role of Diagnosis and Treatment Appathurai Balamurugan MD, MPH S William Ross MD Chris Fisher, BS Jim Files,
Supraclavicular metastasis from urothelial bladder carcinoma: A case report S. Farmahan, T. Mirza, P. Ameerally Oral Maxillofacial Department, Northampton.
Urothelial tumors Tumors in the collecting system above the bladder are relatively uncommon. These tumors are classified into : 1 benign papilloma. 2-papillary.
Kidney Cancer – All You Need to Know!
Carcinoma of the urinary bladder in a tertiary care setting in a developing country Farhana Badar, Ambreen Sattar, Fouzia Meerza, Noreen Irfan, Neelam.
DEPT OF RADIATION ONCOLOGY Prognostic Value of Post-Radiotherapy FDG PET in Head and Neck Cancer after Intensity Modulated Radiation Treatment Heming Lu.
Department of Hemato-Oncology MGR review.  Epithelial carcinoma of the head and neck  arised from the mucosal surfaces in the head and meck area  squamous.
Canadian Undergraduate Urology Curriculum (CanUUC): Hematuria
Metastatic sarcoma to the nasal bone
Bladder Cancer and Prostatic Cancer
Clinicopathological features and outcome of Head & Neck Cancer in Pakistan 1A Jamshed, 1R Hussain, 2S Jamshed, 1A A Syed, 1A Loya, 1M A Shah, 1U Majeed.
J. Edson PontesM.D. Professor Urologic Oncology WSU/KCI
Fig. 1c: Cystoprostatectomy specimen
NECK MASSES.
Laparoscopic vs Open Colonic Surgery: Long Term Survival
Lung Cancer Screening:
Rossi A et al. Proc ASCO 2011;Abstract 8008.
Apollo Gleneagles Hospitals,
HEPATOCELLULAR CARCINOMA (HCC) at
Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance  Adam B. Weiner, Ruth Etzioni, Scott E. Eggener 
Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study  Stephen H. Culp, Paul.
Role of cytokeratins in the diagnosis and prognosis of the bladder cancer Giorgi Adeishvili MD Multiprofile clinic Consilium Medulla.
POEM Group Online Case Discussion Date: April 1, 2014
Management of endometrial cancer found on routine hysterectomy for benign disease Prof Dr M Anıl Onan MAY ANTALYA.
Urinary bladder cancer
1.6 U.6 Mutagens, oncogenes and metastasis are involved in the development of primary and secondary tumours. Tumours are abnormal growth of tissue that.
Megan Eguchi, MPh Sana karam, md, phd
Does PSA Testing Influence the Natural History of Prostate Cancer?
History: 71 yo male post radical prostatectomy 4 years ago for Gleason 4+5 prostate cancer Pre-op staging CT and MDP bone scan were negative for metastatic.
An Evaluation of Prostate Volume and Proton Therapy-Related Toxicities
Standardised follow-up
Presentation transcript:

Correlations between Urologic and Head and Neck Cancers John R Jacobs MD Edson J Pontes MD Karmanos Cancer Center Wayne State University

Case Report 57 y/o male smoker (2PPD x42yr) construction worker 4/2004 Rt neck swelling dx metastatic squamous cell cancer UNK Primary Treated with MND post op RT/CT 5/2006 Renal mass ID on routine CT of thorax for HN Ca Laparoscopic Assisted Left Radical Nephrectomy Clear cell (Furman Grade 3) 6.2 cm T1NxMo organ confined

Case Report (con) 12/2008 elevation PSA Prostate Biopsy negative 8/2009 Gross painless hematuria 8cm left lateral wall urinary bladder Low grade non invasive papillary urothelial ca

Case Report (con) 3/2010 Surveillance cysto small recurrence bladder neck 10/2010 recurrence two areas 5/2011 Surveillance cysto pending

Question Is it reasonable to prospectively screen head and neck cancer patients for urologic malignancies?

Hypothesis There exists a significant number of patients with both head and neck and urologic malignancies because of similar risk factors

Background

Known Etiologic Factors for Head and Neck Cancer Tobacco products Alcohol Betel nut usage Aniline dyes Woodworkers Nickel refiners Paint fumes Petroleum industry chemicals Human papillomavirus Epstein barr virus (nasopharyngeal)

Known Etiologic Factors for Urologic Cancer Tobacco Aniline dyes Rubber manufacturing Textile printing Cyclophosphamide or ifosfamide Pelvic irradiation Schistosomiasis Chronic irritation (Foley) Phenacetin

Common Etiologic Factors Tobacco Aniline dyes Petroleum industry products

Methodology SEER data base Surveillance Epidemiology and End Results

Methodology Established in 1973 Covers roughly 26% of the USA population Cancer incidence and survival from population based data bases Both academic and community hospitals participate

Results

Participating Sites

Total Cases

Frequency by Years

Sex by Site

Site and Stage

Sequence

Conclusions

Majority of patients are male Conclusions Majority of patients are male

Conclusions Majority of patients are male Distant disease at presentation is unusual

Conclusions Majority of patients are male Distant disease at presentation is unusual More undifferentiated cancers in urology

Conclusions Majority of patients are male Distant disease at presentation is unusual More undifferentiated cancers in urology More regional disease in head and neck

128,650 Head and Neck 237,509 Urologic ONLY 2462 with both Total Cases 128,650 Head and Neck 237,509 Urologic ONLY 2462 with both

Conclusion Less than 1% of patients will have both head and neck and urologic cancers

Hypothesis There exists a significant number of patients with both head and neck and urologic problems because 60 year males with a past history of tobacco usage are common in both groups

Unique patients seen at KCI

Conclusion Less than 2% patients are see jointly between Head and Neck and Urology

Conclusion Two busy surgeons who refer to each other see a number of patients in common

Conclusion The incidence of joint problems in the head and neck and the urologic cancer population is too low to justify screening

Patient Characteristics H&N URO

Patient Characteristics H&N URO

Patient Characteristics H&N URO

Patient Characteristics

Patient Characteristics H&N URO